Table 3

Hematologic parameters of GbG mice that underwent transplantation following reduced-intensity conditioning

Time point/mouse typenWBC, 103/μLRBC, 106/μLHb, g/dLMCV, fLMCH, pgRDW, %Plt, 103/μLReticulocyte, %
Week 12          
    Mock 21.7 ± 3.8 6.1 ± 0.7 7.9 ± 0.7 46.2 ± 2.3 12.5 ± 0.2 27.0 ± 1.4 839 ± 86 53.2 ± 3.9 
    GbG≥10 14 32.3 ± 4.6 7.4 ± 0.3 7.9 ± 0.4 41.7 ± 0.7 10.7 ± 0.3 29.1 ± 0.5 737 ± 36 20.2 ± 2.5 
    P*  .6 .16 .96 .12 .001 .2 .3 .001 
Week 18          
    Mock 32.3 ± 4.6 5.6 ± 0.1 6.8 ± 0.2 46.9 ± 1.3 12.2 ± 0.3 31.4 ± 0.9 802 ± 91 54.5 ± 2.3 
    GbG≥10 12.9 ± 1.4 7.7 ± 0.4 8.9 ± 0.4 43.2 ± 1.5 11.7 ± 0.6 28.8 ± 0.8 798 ± 97 26 ± 4.1 
    P  .01 .002 .001 .09 .57 .07 .97 .0001 
Week 24          
    Mock 34.1 ± 9.4 5.6 ± 0.3 7.4 ± 0.3 48.7 ± 2.4 13.2 ± .0.3 30.1 ± 1.9 780 ± 100 50.8 ± 1.9 
    GbG≥10 13.4 ± 1.1 8.1 ± 0.5 9.3 ± 0.6 43.9 ± 1.2 11.3 ± 0.2 29.8 ± 1.1 764 ± 61 21.2 ± 1.9 
    P  .07 .003 .04 .1 .002 .9 .9 .001 
Time point/mouse typenWBC, 103/μLRBC, 106/μLHb, g/dLMCV, fLMCH, pgRDW, %Plt, 103/μLReticulocyte, %
Week 12          
    Mock 21.7 ± 3.8 6.1 ± 0.7 7.9 ± 0.7 46.2 ± 2.3 12.5 ± 0.2 27.0 ± 1.4 839 ± 86 53.2 ± 3.9 
    GbG≥10 14 32.3 ± 4.6 7.4 ± 0.3 7.9 ± 0.4 41.7 ± 0.7 10.7 ± 0.3 29.1 ± 0.5 737 ± 36 20.2 ± 2.5 
    P*  .6 .16 .96 .12 .001 .2 .3 .001 
Week 18          
    Mock 32.3 ± 4.6 5.6 ± 0.1 6.8 ± 0.2 46.9 ± 1.3 12.2 ± 0.3 31.4 ± 0.9 802 ± 91 54.5 ± 2.3 
    GbG≥10 12.9 ± 1.4 7.7 ± 0.4 8.9 ± 0.4 43.2 ± 1.5 11.7 ± 0.6 28.8 ± 0.8 798 ± 97 26 ± 4.1 
    P  .01 .002 .001 .09 .57 .07 .97 .0001 
Week 24          
    Mock 34.1 ± 9.4 5.6 ± 0.3 7.4 ± 0.3 48.7 ± 2.4 13.2 ± .0.3 30.1 ± 1.9 780 ± 100 50.8 ± 1.9 
    GbG≥10 13.4 ± 1.1 8.1 ± 0.5 9.3 ± 0.6 43.9 ± 1.2 11.3 ± 0.2 29.8 ± 1.1 764 ± 61 21.2 ± 1.9 
    P  .07 .003 .04 .1 .002 .9 .9 .001 

Hematologic parameters and abbreviations as stated in Table 1. P values represent comparisons of mock mice with GbG≥10 at 12 (*), 18 (†), and 24 weeks (‡).

or Create an Account

Close Modal
Close Modal